Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
The Republican Recap: Week of August 31, 2026
Majority Leader Louisiana
Here's a recap of what Republicans achieved on the House floor this week: Condemning Socialism and Protecting American Elections ✅ Socialism is one of the most destructive ideologies in world history, time and time again proving itself to be a...
T3 Defense Subsidiary Tiltan to Exhibit at MSPO 2026, Advancing NATO Market Expansion
GlobeNewswire, Inc.
Poland exhibition opens NATO member and allied procurement channels to Tiltan’s software portfolio TOPS simulation, Majestic.ai synthetic data, T-VERSE, T-SAR, T-BAT and AGM on display in Kielce, September 8–11, 2026 NEW YORK and NETANYA, Israel,...
Alpha Tau to Participate in September Investor Conferences
GlobeNewswire, Inc.
JERUSALEM, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will...
QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors
GlobeNewswire, Inc.
Ness Ziona, Israel, Aug. 19, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure, today announced a...
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
GlobeNewswire, Inc.
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced it has completed the transition of its NanoVibronix manufacturing operations...
TruGolf to Acquire Polymath Research Inc., Bringing Tokenization Innovator to the Public Markets on Nasdaq
GlobeNewswire, Inc.
Polymath to become one of the first Layer-1 Blockchain companies in the public markets on the NASDAQ Stock Exchange via a business combination with TruGolf Holdings, Inc., making institutional-grade tokenization accessible to the financial...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alarum Technologies Ltd. of Class Action Lawsuit and Upcoming Deadlines – ALAR
GlobeNewswire, Inc.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQ: ALAR). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rackspace Technology, Inc. of Class Action Lawsuit and Upcoming Deadlines – RXT
GlobeNewswire, Inc.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rackspace Technology, Inc. (“Rackspace” or the “Company”) (NASDAQ: RXT). Such investors are advised to contact Danielle Peyton...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – BYAH
GlobeNewswire, Inc.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (“Park Ha” or the “Company”) (NASDAQ: BYAH). Such investors are advised to contact...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ZoomInfo Technologies Inc. of Class Action Lawsuit and Upcoming Deadlines – GTM
GlobeNewswire, Inc.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ZoomInfo Technologies Inc. (“ZoomInfo” or the “Company”) (NASDAQ: GTM). Such investors are advised to contact Danielle Peyton at...
Steakholder Foods Launches Perfecta™ at Retail Outlets Across the Northeastern U.S.
GlobeNewswire, Inc.
Ness Ziona, Israel, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (Nasdaq: STKH), a global leader in 3D-printing technology for production of whole cuts of plant-based meat, today announced the launch of Perfecta™ Premium Plant-Based...
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
GlobeNewswire, Inc.
Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced its...
Ever After Foods Acquires Fishway to Expand Integrated Food Production Technology Platform
GlobeNewswire, Inc.
HAIFA, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Ever After Foods (EAF) today announced the strategic acquisition of Fishway, representing an important milestone in the company's long-term strategy to expand its industrial protein manufacturing...
Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform
GlobeNewswire, Inc.
Norwalk, CT, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology company assembling an AI-powered, quantum-accelerated System-of-Systems platform...
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
GlobeNewswire, Inc.
RAMAT GAN, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) (“Can-Fite” or the “Company”), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs...
Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential
GlobeNewswire, Inc.
Teva-discovered TEV ‘408, a novel anti-IL-15 monoclonal antibody, demonstrated statistically significant and clinically meaningful prevention of gluten-induced intestinal damage vs placebo following a single subcutaneous dose.
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
GlobeNewswire, Inc.
Company plans to advance the interim analysis of its Phase III Namodenoson study in advanced hepatocellular carcinoma Ramat Gan, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a...
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
GlobeNewswire, Inc.
Raanana, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, recently announced that it...
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire, Inc.
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference YAVNE, Israel, September 2, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced...
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears the site to commence patient screening...
Sign up for:
Tech World Israel
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.